Abstract
Non-invasive stereotactic radioablation of ventricular tachycardia (VT) substrate has been proposed as anovel treatment modality for patients not eligible for catheter-based ablation or in whom this approach has failed. Initial clinical results are promising with good short-term efficacy in VT suppression and tolerable side effects. This article reviews the current clinical evidence for cardiac radioablation and gives an overview of important preclinical and translational results. Practical guidance is provided, and acardiac radioablation planning and treatment workflow based on expert consensus and the authors' institutional experience is set out.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
